ENANTA PHARMA GAAP EPS OF -$0.67 MISSES BY $0.16, REVENUE OF $14.35M MISSES BY $2.47M - SEEKINGALPHA

FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →

FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →

SCOTT BESSENT SURPRISE BOND BUYBACK SPARKS A SILVER RALLY . IS IT TOO LATE TO BUY IN ? →